BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10223569)

  • 1. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
    Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
    Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
    Louie DC; Offit K; Jaslow R; Parsa NZ; Murty VV; Schluger A; Chaganti RS
    Blood; 1995 Oct; 86(8):2892-9. PubMed ID: 7579380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression in patients with multiple myeloma.
    Troussard X; Avet-Loiseau H; Macro M; Mellerin MP; Malet M; Roussel M; Sola B
    Hematol J; 2000; 1(3):181-5. PubMed ID: 11920187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene.
    Vaandrager JW; Kluin P; Schuuring E
    Blood; 1997 Jan; 89(1):349-50. PubMed ID: 8978314
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
    Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
    Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
    Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
    Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
    Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E
    Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
    Chinen Y; Tsukamoto T; Maegawa-Matsui S; Matsumura-Kimoto Y; Takimoto-Shimomura T; Tanba K; Mizuno Y; Fujibayashi Y; Kuwahara-Ota S; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
    Exp Hematol; 2020 Apr; 84():45-53.e1. PubMed ID: 32145384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of clonal relationship using single-cell polymerase chain reaction in a patient with concomitant mantle cell lymphoma and multiple myeloma.
    Yamaguchi M; Ohno T; Miyata E; Toyoda H; Nishii K; Masuya M; Kita K; Shiku H
    Int J Hematol; 2001 Apr; 73(3):383-5. PubMed ID: 11345207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519).
    Jadayel DM; Lukas J; Nacheva E; Bartkova J; Stranks G; De Schouwer PJ; Lens D; Bartek J; Dyer MJ; Kruger AR; Catovsky D
    Leukemia; 1997 Jan; 11(1):64-72. PubMed ID: 9001420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
    Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
    Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes.
    Nagai M; Fujita M; Ohmori M; Matsubara S; Taniwaki M; Horiike S; Tasaka T; Koeffler HP; Takahara J
    Hematol Oncol; 1997 Aug; 15(3):109-19. PubMed ID: 9600110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32).
    Janssen JW; Vaandrager JW; Heuser T; Jauch A; Kluin PM; Geelen E; Bergsagel PL; Kuehl WM; Drexler HG; Otsuki T; Bartram CR; Schuuring E
    Blood; 2000 Apr; 95(8):2691-8. PubMed ID: 10753852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
    Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
    Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain.
    Walters DK; Arendt BK; Tschumper RC; Wu X; Jelinek DF
    Exp Hematol; 2018 Jan; 57():42-49.e1. PubMed ID: 29030084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
    Lai R; McDonnell TJ; O'Connor SL; Medeiros LJ; Oudat R; Keating M; Morgan MB; Curiel TJ; Ford RJ
    Leuk Res; 2002 Sep; 26(9):849-55. PubMed ID: 12127561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma.
    Fiel-Gan MD; Almeida LM; Rose DC; Takano A; Rezuke WN; Coleman WB; Garcia NF; Tsongalis GJ
    Int J Mol Med; 1999 Apr; 3(4):373-9. PubMed ID: 10085408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1.
    Yata K; Sadahira Y; Otsuki T; Sakaguchi H; Isozaki Y; Uno M; Kurebayashi J; Fujii T; Eda S; Ueki A; Yawata Y; Yamada O; Sugihara T
    Br J Haematol; 2001 Sep; 114(3):591-9. PubMed ID: 11552984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.